Leah Geller

Canadian manufacturing of CAR-T cells a game-changer for cancer patients and researchers

Leah Geller
August 10, 2022

A pioneering clinical trial by The Ottawa Hospital is using made-in-Canada genetically engineered T calls, called CART-T cells, to keep cancer patients alive and cancer-free.

... Please become a Member or login to read the rest of this article ...


Other stories mentioning these organizations, people and topics
Organizations: Algonquin College, BC Cancer, BioCanRx network, Canada Foundation for Innovation, Government of Canada, Mitacs, Ontario Institute for Cancer Research, The Ottawa Hospital, The Ottawa Hospital Foundation, The Ottawa Hospital's Biotherapeutics Manufacturing Centre, and University of Ottawa
People: Dr. Jennifer Quizi
Topics: biologics manufacturing, Canada's biomanufacturing sector, Canadian Partnership for Research in Immunotherapy Manufacturing Excellence, Canadian-Led Immunotherapies in Cancer-01 clinical trial, CAR-T therapies, made-in-Canada immunotherapies, and training in biotherapeutics manufacturing

Other News

The Short Report - August 10, 2022: A new CEO for C100; Stem Cell Network launches last funding competition for 2022-2025, Alberta tech investments soar, and more

GHGSat seeks methane from space to help Canada tackle global warming

SR&ED program requires major reforms to stimulate business R&D: policy brief

NSERC initiatives geared at mobilizing knowledge on a global scale






Events For Leaders in
Science, Tech, Innovation, and Policy


Discuss and learn from those in the know at our virtual and in-person events.



See Upcoming Events










You have 0 free articles remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in






Top

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.